Tag Archives: cured

Judge’s Findings of Fact + Proposed Decision / Recap: Texas vs. Dr. Burzynski, trial May 3-13, 2016

UPDATE: October 12, 2016: Texas vs. Dr. Burzynski: Judge’s release their Proposed Decision – Full videos and video highlights from trial below:

READ THE ENTIRE 221-PAGE JUDGE’S PROPOSED DECISION HERE (PDF). A few excerpts from the final “Proposed Decision” from the “Texas Medical Board vs. Dr. Stanislaw Burzynski” hearings in 2015-2016: Page 187-188 (pages #’s not PDF pages) “Findings Of Fact”:
Respondent has devoted his career as a physician to finding a cure for cancer. In that endeavor, he worked at Baylor College of Medicine and received funding from the National Cancer Institute (NCI) to research the link between peptides in blood and cancer growth. After Respondent opened the Clinic in 1977, he focused on treating terminally ill cancer patients, those patients who either chose not to try traditional cancer treatment or tried conventional cancer treatment and were not cured. In 1990, Respondent began providing what has since become known as personalized therapy to treat the cause of the cancer. Respondent discovered and patented a new drug, [Antineoplastons] ANP. In 1993, the FDA approved ANP for a clinical trial with Respondent serving as the investigator. Since that time, the FDA has approved approximately 65 prospective clinical trials and one retrospective clinic trial with Respondent serving as the principal investigator. It is uncommon for a person who has discovered an investigational drug to be able to run clinical trials without the financial support of a pharmaceutical company or NCI. According to Dr. Levin, Respondent has completed phase II FDA trials and the FDA has given permission on some to proceed to phase III trials. In Dr. Levin’s opinion, Respondent is a “medical pioneer.” Because of Respondent’s research on ANP and its analogues such as PB, Dr. Levin stated that “there is now acceptance of the fact that these compounds have anti-cancer activity.” Using targeted agents in combination is a therapeutic leap. Dr. Levin stated: Dr. Burzynski should be credited for discovering a family of compounds which have shown anti-cancer activity and have had impressive results in patients treated in clinical trials, at least in the parameter in having long—term survivors in brain tumors where surviving the disease is relatively uncommon.
Page 210 (pages #’s not PDF pages) “Findings Of Fact”:
• For almost 40 years, Respondent has devoted himself to treating terminally ill cancer patients who have either rejected conventional cancer treatments or had tried conventional treatments without success. Some of Respondent’s treatments have become more accepted and mainstream. • If Respondent is unable to continue practicing medicine, critically ill cancer patients being treated with ANP under FDA-approved clinical’trials or a special exception will no longer have access to this treatment. • Respondent’s continued practice in treating advanced cancer patients is a present value to the cancer community. • Respondent’s treatments have saved the lives of cancer patients, both adults and children, who were not expected to live.
READ THE ENTIRE 221-PAGE JUDGE’S PROPOSED DECISION HERE (PDF). Sign up for the mailing list below and follow this project on Facebook to be notified of updates as we continue to add more videos to this page.

Subscribe to the Burzynski Film Series mailing list

* indicates required
*It’s now up to the Texas Medical Board to “review” the judge’s findings and decide to proceed in their efforts to remove Dr. Burzynski’s medical license, give up and accept their losing battle, or spend another several years trying to suppress him by taking him to court again (not like they have begun giving up yet). Please subscribe to the mailing list, follow on Facebook, or keep checking back to see the additional footage and updates to these proceedings. Attorney, Judges, and Burzynski highlights from May 3-13, 2016. 1. May 3, 4, 5, 2016 – Dr. Burzynski takes the witness stand. (Full testimony coming soon) Burzynski patients remember – in Austin, TX during the 2016 leg of the trial: 2(a). May 6, 2016 – Mary Michaels takes the witness stand. Mary Michael’s son Paul was diagnosed with an inoperable optic-hypothalamic glioma astrocytoma brain tumor. He was cured of his brain cancer by Burzynski’s Antineoplastons. 2(b). May 6, 2016 – Mary Jo Siegel takes the witness stand. Mary Jo Siegel was diagnosed with Stage IV non-Hodgkin’s lymphoma, and was cured by Burzynski’s Antineoplastons. 2(c). May 6, 2016 – Dr. Greg Burzynski takes the witness stand. The Texas Medical Board (TMB) is also attempting to remove the license of Burzynski’s son, Dr. Gregory Burzynski — the TBM is going after the entire medical staff. dr-b-may-3 (Full video coming soon) 3(a). May 9, 2016 – Mary Susan McGhee takes the witness stand. Mary Susan McGhee was cured of Stage IV esophageal cancer by Burzynski’s “gene-targeted cancer regimin” which also includes Phenylbutyrate (PB). 3(b). May 9, 2016 – Oncologist Dr. Mark Levin takes the witness stand. Dr. Mark Levin gives his witness testimony on behalf of Dr. Burzynski’s operation and patients as an expert oncologist. dr-b-may-3 (Full video coming soon) 3(b). May 10, 2016 – Medical Records. Due to HIPPA laws, we couldn’t record this day. It was rather amusing with the Texas State’s attorney’s said: “why is there no measurement here?”, Burzynski replies, “because the tumor went away,”, but she asked again, “but why no measurement?” – Burzynski said again, “because the tumor resolved, it went away!” 4(a). May 11, 2016 – Burzynski’s Dr. Marquis takes the witness stand. Dr. Marquis gives his testimony while working as a general practitioner for Dr. Burzynski. dr-b-may-3 (Full video coming soon) 4(b). May 11, 2016 – Robin Ressell takes the witness stand. Robin’s daughter Jessica (from Burzynski Part 1) was cured of a DIPG – which has never been cured in medical history outside of Burzynski’s clinical trials. 4(c). May 11, 2016 – Margaret Manning takes the witness stand. Mrs. Manning was cured of Stage IV non-Hodgkin’s lymphoma using Burzynski’s “personalized gene-targeted therapy”. 5. May 12, 2016 – Texas calls back Cynthia Wetmore via telephone. When asked if she knew that all of Burzynski’s patients were terminal when seeking the help of the Burzynski Clinic, Cynthia replied, “aren’t we all terminal, aren’t we all going to die one day?” dr-b-may-3 (Full video coming soon)
(We have dozens of hours of footage from this trial we are trying to post for the public ASAP – subscribe the mailing list or follow us on Facebook to make sure you don’t miss it when it’s all up!)

Subscribe to the Burzynski Film Series mailing list

* indicates required




CLICK: (2016): Instantly watch the new BURZYNSKI: CANCER CURE COVER-UP (2016) 1 hour, 50 min
Your rental or purchase of this new release helps to support and maintain our ability to keep this story alive and in the public’s eye, only $5.00.
Please donate a buck or two to help us keep this public awareness alive!


Under “SIGNit”, sign the Joe Biden petition

Read the summary of the first leg of the trial (November 19-25, 2015) + watch all testimony unedited

Lt. Col. James Treadwell – Glioblastoma Multiforme Grade IV – Cured with Medical Records – brain cancer

James Treadwell was diagnosed with a Glioblastoma Multiforme Grade IV brain tumor in 2004. He has been cancer-free since 2006. An MRI performed in 2010 has confirmed that he is still cancer-free today.

#1 Diagnosis: Pathologists performed a biopsy at the Naval Medical Center in San Diego, CA establishing his diagnosis [PDF]. A second opinion was sought at the UCLA Medical Center which also verified his diagnosis [PDF]. See the Baseline MRI: 9/22/2004 [view image].

#2 Prior Treatment: Prior to Antineoplaston treatment, James Treadwell underwent two surgeries (craniotomies), a Gliadel wafter placement, six weeks of standard radiation treatment (from June 22 to August 4, 2004), three cycles of Temodar® chemotherapy (from June 23 to August 20, 2004). None of these treatments cured Mr. Treadwell of his cancer. In fact, after the second surgery no residual cancer was found, and after the course of radiation and chemotherapy his cancer had returned and doubled in size by September 14, 2004.

#3 Recovery: After two surgeries, a Gliadel wafer, and 6 weeks of both chemotherapy and radiation failed to rid Mr. Treadwell of his brain cancer—on September 24, 2004 James Treadwell was admitted for administration of Antineoplaston treatment. He did not receive any other treatment other than Antineoplaston treatment after September 24, 2004. On November 30, 2006 his cancer was gone [PDF of tumor measurements]. [PDF of ANP treatment summary]; [11/30/2006 MRI image]; [11/2008 MRI image].

#4 Treating Glioblastoma Multiforme Grade IV without Antineoplastons.
In 2010, some German scientists have admitted total defeat: “For patients with relapsed GBM [Glioblastoma Multiforme] there is currently no standard systemic therapy.”

The New England Journal of Medicine Published a study from 2005 stated: “Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this trial we compared radiotherapy alone with radiotherapy plus temozolomide [Temodar®], given concomitantly with and after radiotherapy, in terms of efficacy and safety.” This is the same treatment Mr. Treadwell received prior to being treated with Antineoplastons.

It should be noted that Senator Ted Kennedy died of Glioblastoma Grade IV brain cancer. Countless Glioblastoma survivors cured by Antineoplastons as well as many other people cured of other types of cancer due to Antineoplastons flooded Kennedy’s office to share with him the existence of Antineoplastons. Mr. Kennedy’s wife wrote the Burzynski’s Clinic requesting all communication from Antineoplaston treated cancer survivors stop contacting his office entirely. A year later, Kennedy was dead. Lt. Col. James Treadwell’s medical records are published by written authorization by Lt. Col. James Treadwell.